Environmental, Social & Governance Report – FY 2024

We believe that by advancing the health of women, we advance the health of society. Our ESG priorities are embedded throughout our business, where we focus on the issues that matter most to our stakeholders, our company, and women around the world. This is our latest FY 2024 report.

Learn more

Uninterrupt Your Contraception

In Australia, there are 16 types of contraception options available including not everyday options like long-acting reversible contraception, and everyday options like the pill or mini-pill. With 93% of women getting the contraception choice they ask for, it’s important to know what's available.

Visit the website

The Path to Parenthood

Your path to parenthood is unique, and we recognise that it comes with its own set of questions and uncertainties. That’s why we’ve created this space where you can gain insights and answers and hear from others experiences.

Visit the website

The Impact of Unintended Pregnancies in Australia

The report outlines the significant social and broader health impact of unintended pregnancy in Australia. The results highlight the need to address reproductive healthcare in Australia, to empower women to make the best health choices for their circumstances.

Read the Report

The Impact of Unintended Pregnancies in Australia by State and Territory

This report provides further detailed analysis of the financial, social and broader health impact of unintended pregnancy in Australia by state and territory including direct costs, indirect costs and the impact and the comparison of non-rural vs. rural pregnancies in each state and territory

Read the Report

Organon Women's Fertility Study

The study captures and analyses the responses from a quantitative online survey of over 2,000 women aged 18 – 45 years. The aim of this study is to understand women's perceptions and their attitudes.

Read the Report

Australian Woman and Migraine Study

For Australian women, migraine can affect every facet of their life. This study reveals the social economic and physical impact of migraine on more than 1,000 Australian women aged 21-50.

Read the Infographic

Biosimilar Policy Roadmap

This report outlines the potential of Biosimilars in Australia including an analysis of manufacturing and R&D, health technology assessment, pricing & reimbursement, contracting, education & understanding of Biosimilars, and more.

Read the Report

Environmental, Social & Governance Report – FY 2021

This FY 2021 report outlines how our ESG strategy is being implemented and embraced across the organisation globally. This report details our considerable progress in our inaugural year as a standalone company, as well as the goals we have set for the years ahead.

Read the Report